Abercrombie & Fitch's stock soars 16% after earnings trounce estimates and company raises guidance
Abercrombie & Fitch Co.'s stock (ANF) soared 16% in premarket trade Wednesday, after the teen clothing retailer blew past estimates for the second quarter and raised guidance. The New Albany, Ohio-based company had net income of $56.9 million, or $1.10 a share, after a loss of $16.8 million, or 33 cents a share, in the year-earlier period. Adjusted per-share earnings also came to $1.10, well ahead of the 17 cent FactSet consensus. Sales rose to $935.3 million from $805.1 million, also ahead of the $844.0 million FactSet consensus. Same-store sales rose 13%, while FactSet expected a 4.3% rise. "We continue to see strong customer receptivity of our brands and product, led by 26% net sales growth in Abercrombie brands," CEO Fran Horowitz said in a statement. The company raised its full-year guidance and now expects sales to grow 10%, up from prior guidance of up 2% to 4%. It expects third-quarter sales to rise by low double-digits. The stock has gained 80% in the year to date, while the S&P 500 has gained 14%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-23-23 0742ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
How to Invest Like Warren Buffett
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025